📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Novel hypervariable erythrocyte surface expressed recombinant proteins show promise as serological markers of exposure to Plasmodium falciparum infection (2023)

First Author: Vasileva H

Attributed to: Adjunctive Ivermectin Mass Drug Administration for Malaria Elimination: A cluster randomized trial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.10.31.564916

Publication URI: http://dx.doi.org/10.1101/2023.10.31.564916

Type: Preprint